2020
The President, Past President, Executive Director, and the Board of the Child Neurology Society Denounce Racism and Inequality
Pearl P, Mink J, Cohen B, Bamford N, Bass N, Jordan L, Wainwright M, Larson R. The President, Past President, Executive Director, and the Board of the Child Neurology Society Denounce Racism and Inequality. Annals Of Neurology 2020, 88: 209-210. PMID: 32567711, DOI: 10.1002/ana.25828.Peer-Reviewed Original Research
2019
Localising movement disorders in childhood
Bamford NS, McVicar K. Localising movement disorders in childhood. The Lancet Child & Adolescent Health 2019, 3: 917-928. PMID: 31653548, PMCID: PMC7102738, DOI: 10.1016/s2352-4642(19)30330-x.Peer-Reviewed Original ResearchConceptsMovement disordersBasal gangliaBasal ganglia functionMajor movement disordersGanglia functionNew pharmacologicalTreatment decisionsClinical definitionSynaptic functionElectrophysiological approachesDisordersMotor learningGangliaChildrenIon channelsThalamusCortexPharmacologicalDiseasePhysiological frameworkDiagnosisNeuronsReceptors
2009
Neuromuscular hip dysplasia in Charcot–Marie–Tooth disease type 1A
BAMFORD NS, WHITE KK, ROBINETT SA, OTTO RK, GOSPE SM. Neuromuscular hip dysplasia in Charcot–Marie–Tooth disease type 1A. Developmental Medicine & Child Neurology 2009, 51: 408-411. PMID: 19388151, DOI: 10.1111/j.1469-8749.2008.03234.x.Peer-Reviewed Original ResearchConceptsNeuromuscular hip dysplasiaHip dysplasiaClinical signsCharcot-MarieType 1AInconsistent clinical signsInitial clinical signsTooth disease type 1ACMT type 1APeripheral neuropathyHip diseaseOrthopedic abnormalitiesTooth diseaseNeurological disordersCMT 1A.DysplasiaFrequent formDiseaseSignsChildrenConsiderable variabilityNeuropathySymptomsAbnormalitiesDiagnosis